Kinetic characterization and molecular docking of novel allosteric inhibitors of aminoglycoside phosphotransferases

This study gives new insights into the inhibition of APHs by such allosteric inhibitors, and provides the basis for the future development of combined therapies, antibiotic plus APH inhibitor, which may reverse the resistance to aminoglycosides in a clinical context.